维普期刊资源整合服务平台（V6.5）

33篇 您的检索式：作者名="Lewanczuk RZ"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Vascular compliance is reduced in the early stages of type 1 diabetes显示文摘	Romney JS Lewanczuk RZ	2001	Diabetes Care2001，24，12：	1
2	Improvements in patient-reported outcomes associated with an intervention to enhance quality of care for rural patients with type 2 diabetes: Results of a controlled trial显示文摘	Maddigan SL Majumdar SR Guirguis LM Lewanczuk RZ Lee TK Toth EL Johnson JA	2004	Diabetes Care2004，27，6：	1
3	Vascular compliance is reduced in the early stages type 1 diabetes显示文摘	Romney JS Lewanczuk RZ	2001	Diabetes Care2001，24，：	1
4	A novel,non-invasive13 C-glucose breath test to estimate insulin resistance in obese prepu-bertal children显示文摘	Jetha MM Nzekwu U Lewanczuk RZ	2009	J Pediatr Endocrinol Metab2009，22，11：	1
5	Of the renin - angiotensin system and reac- tive oxygen species type 2 diabetes and angiotensin lI inhibition 显示文摘	Leiter LA Lewanczuk RZ	2005	Am J Hypertens2005，18，1：	1
6	Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin Ⅱ inhibition显示文摘	Lewanczuk RZ	2005	Am J Hypertens2005，18，：	1
7	Comparison of theglu-cose breath test to the hyperinsulinemic-euglycemic clamp whendetermining insulin resistance显示文摘	Lewanczuk RZ Paty BW Toth EL	2004	Diabetes Care2004，27，2：	1
8	Parathyroid hypertensive factor and intracellular calcium regulation显示文摘	Pang PK Shan JJ Lewanczuk RZ	1996	J Hypertens1996，14，9：	1
9	Parathyrod bypertensive factor and intraceUular calcitmi regulation 显示文摘	Pang PK Shan JJ Lewanczuk RZ	1996	J Hypertens1996，14，9：	1
10	Vascular compliance is reduced in the early stages of type 1 diabetes显示文摘	Romney JS Lewanczuk RZ	2001	Diabetes Care2001，24，12：	1
11	High-performance liquid chromatographic analysis of angiotensin Ⅱ receptor antagonist valsartan using a hquid extraction method显示文摘	Daneshtalab N Lewanczuk RZ Fakhreddin J	2002	J Chromatogr B2002，766，：	1
12	Arterial Compliance in Young Children: the Role of Aerobic Fimess 显示文摘	Reed KE Warburton DE Lewanczuk RZ	2005	Eur J Cardlovasc Prey Relmbil2005，12，5：	1
13	2010 Canadian hypertension education program ( CHEP) recommendations : the scientific summary-an update of the 2010 theme and the science behind new CHEP recommendations显示文摘	Campbell NR Kaczorowski J Lewanczuk RZ	2010	Can J Cardiol2010，26，5：	1
14	Resistant hypertension:An overview显示文摘	McAlister FA Lewanczuk RZ Teo KK		0，，：	1
15	Of the rennin-angiotensin system and reactive oxygen species: type 2 diabetes and angiotensin II inhibition显示文摘	LEITER LA LEWANCZUK RZ	2005	Am J Hypertcns2005，18，1：	1
16	Resistant hypertension:an overview显示文摘	Mcalister FA Lewanczuk RZ Teo KK	1996	Can J Cardiol1996，12，9：	1
17	High-performance liquid chromatographic analysis of angiotensin Ⅱ receptor antagonist valsartan using a liquid extraction method显示文摘	Daneshtalab N Lewanczuk RZ Jamali F	2002	J Chronatogr B2002，766，6：	1
18	Hyperplacentosis : A novel cause of hyperthyroidism 显示文摘	Ginsberg J Lewanczuk RZ Honore LH	2001	Thyroid2001，11，4：	1
19	Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin Ⅱ inhibition显示文摘	Leiter LA Lewanczuk RZ	2005	Am JHypertens2005，18，1：	1
20	Of the rennin-angiotensinsystem and reactive oxygen species Type 2 diabetes and angiotensin Ⅱ inhibition显示文摘	Leiter LA Lewanczuk RZ	2005	Am J Hypertens2005，18，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示